Literature DB >> 2752110

Molecular cloning of a cDNA encoding canine factor IX.

J P Evans1, H H Watzke, J L Ware, D W Stafford, K A High.   

Abstract

Factor IX (F.IX) is a vitamin K-dependent plasma protein, a deficiency of which results in hemophilia B. A canine model of hemophilia B exists; attempts to use this model for gene transfer experiments or characterization of the hemophilic defect require elucidation of normal canine F.IX structure. We report the isolation and characterization of the coding region for canine F.IX cDNA. Canine F.IX possesses 86% identity at the amino-acid level with human F.IX. The leader peptide, Gla domain, EGF domains, and the carboxy-terminal portion of the heavy chains show extensive sequence conservation between the canine and human. All Glu residues undergoing gamma-carboxylation in humans are conserved in canines. The complete coding sequence for canine F.IX has been determined, and the derived translation product has been analyzed. A similar approach should allow identification of the causative mutation in canine hemophilia B. Furthermore, this clone may prove a valuable resource in gene transfer experiments for this disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2752110

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  19 in total

Review 1.  Adeno-associated virus-mediated gene transfer for hemophilia B.

Authors:  Katherine A High
Journal:  Int J Hematol       Date:  2002-11       Impact factor: 2.490

2.  A rapid test for V(D)J recombinase activity.

Authors:  S Kallenbach; M Goodhardt; F Rougeon
Journal:  Nucleic Acids Res       Date:  1990-11-25       Impact factor: 16.971

3.  Comparative sequence analysis of mammalian factor IX promoters.

Authors:  C P Pang; M Crossley; G Kent; G G Brownlee
Journal:  Nucleic Acids Res       Date:  1990-11-25       Impact factor: 16.971

4.  A mouse model for nonsense mutation bypass therapy shows a dramatic multiday response to geneticin.

Authors:  Chunmei Yang; Jinong Feng; Wenjia Song; Jicheng Wang; Becky Tsai; Yunwu Zhang; William A Scaringe; Kathleen A Hill; Paris Margaritis; Katherine A High; Steve S Sommer
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-19       Impact factor: 11.205

5.  Gene therapy for hemophilia: the clot thickens.

Authors:  Katherine A High
Journal:  Hum Gene Ther       Date:  2014-11       Impact factor: 5.695

6.  Mutations causing hemophilia B: direct estimate of the underlying rates of spontaneous germ-line transitions, transversions, and deletions in a human gene.

Authors:  D D Koeberl; C D Bottema; R P Ketterling; P J Bridge; D P Lillicrap; S S Sommer
Journal:  Am J Hum Genet       Date:  1990-08       Impact factor: 11.025

7.  Missense mutations and evolutionary conservation of amino acids: evidence that many of the amino acids in factor IX function as "spacer" elements.

Authors:  C D Bottema; R P Ketterling; S Ii; H S Yoon; J A Phillips; S S Sommer
Journal:  Am J Hum Genet       Date:  1991-10       Impact factor: 11.025

Review 8.  Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiency.

Authors:  Timothy C Nichols; Aaron M Dillow; Helen W G Franck; Elizabeth P Merricks; Robin A Raymer; Dwight A Bellinger; Valder R Arruda; Katherine A High
Journal:  ILAR J       Date:  2009

Review 9.  Haemophilia: strategies for carrier detection and prenatal diagnosis.

Authors:  I R Peake; D P Lillicrap; V Boulyjenkov; E Briet; V Chan; E K Ginter; E M Kraus; R Ljung; P M Mannucci; K Nicolaides
Journal:  Bull World Health Organ       Date:  1993       Impact factor: 9.408

10.  Phenotypic correction of factor IX deficiency in skin fibroblasts of hemophilic dogs.

Authors:  J H Axelrod; M S Read; K M Brinkhous; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.